Abstract Although anti–HLA (Human Leukocyte Antigen) donor-specific antibodies (DSAs)
are commonly measured in clinical practice and their relationship with transplant outcome is …

Antibody-mediated rejection after liver transplantation is an under-recognised cause of
allograft injury. While definitions of acute and chronic antibody-mediated rejection have …

Liver transplantation (LT) is a life-saving surgical procedure and the current standard of care
for most patients with end stage liver disease. With improvements in organ preservation …

Aim To evaluate the use of donor‐derived cell‐free DNA (dd‐cfDNA) in diagnosing graft
injuries in Japanese liver transplantation (LTx), including family‐related living donors …

Solid organ transplantation represents the best (and in many cases only) treatment option
for patients with end‐stage organ failure. The effectiveness and functioning life of these …

Liver transplantation (LT) is an established life-saving procedure. The field of LT has
changed in the past 10 years from several perspectives, with the expansion of indications …

The management of long-term immune suppressive medication in kidney transplant
recipients is a poorly explored field in the area of transplant medicine. In particular, older …

The liver is considered a tolerogenic organ that can induce peripheral tolerance. The exact
mechanisms of tolerance in the liver remain undefined. Regulatory T cells (Tregs) have …

Objective Newly detected donor HLA‐specific antibodies (DSA) are historically known to be
associated with reduced survival in heart transplant patients. Our objective is to clarify the …

Strategies to minimize immune-suppressive medications after liver transplantation are
limited by allograft rejection. Biopsy of liver is the current standard of care in diagnosing …